We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+12.92%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$132B
AUM Growth
+$1.54B
(+1.2%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-7.87%
Top 10 Holdings %
Top 10 Hldgs %
33.39%
Holding
337
New
10
Increased
60
Reduced
221
Closed
18
Avg Time Held
7.2
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
5.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Synopsys
SNPS
|
+$288M |
| 3 |
IDEX
IEX
|
+$256M |
| 4 |
Booz Allen Hamilton
BAH
|
+$240M |
| 5 |
Netflix
NFLX
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.46B |
| 2 |
Micron Technology
MU
|
+$1.12B |
| 3 |
KLA
KLAC
|
+$773M |
| 4 |
Chevron
CVX
|
+$615M |
| 5 |
Wells Fargo
WFC
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 26.35% |
| 3 | Industrials | 11.65% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Financials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Sony
SONY
$144B
| $1.49B | 1.13% |
58,301,430
-6,140,660
| -10% | -$172M |
2013 Q2
50 quarters
|
|
27
Baidu
BIDU
$28.1B
| $1.45B | 1.1% |
11,103,600
-1,008,700
| -8% | -$125M |
2019 Q4
24 quarters
|
|
28
Visa
V
$750B
| $1.41B | 1.06% |
4,008,951
-55,830
| -1% | -$19M |
2013 Q2
50 quarters
|
|
29
Bristol-Myers Squibb
BMY
$124B
| $1.34B | 1.02% |
24,875,550
+2,781,230
| +13% | +$134M |
2017 Q1
35 quarters
|
|
30
Adobe
ADBE
$97.9B
| $1.29B | 0.97% |
3,676,206
-181,299
| -5% | -$61.7M |
2013 Q2
50 quarters
|
|
31
GSK
GSK
$98.2B
| $1.23B | 0.93% |
25,130,160
-636,790
| -2% | -$29.7M |
2013 Q2
50 quarters
|
|
32
Delta Air Lines
DAL
$51.4B
| $1.22B | 0.92% |
17,594,127
-699,860
| -4% | -$43.7M |
2013 Q2
50 quarters
|
|
33
Thermo Fisher Scientific
TMO
$258B
| $1.19B | 0.9% |
2,057,292
-246,030
| -11% | -$139M |
2013 Q4
48 quarters
|
|
34
Oracle
ORCL
$408B
| $1.18B | 0.89% |
6,031,740
-1,504,586
| -20% | -$358M |
2013 Q2
50 quarters
|
|
35
JPMorgan Chase
JPM
$891B
| $1.16B | 0.88% |
3,606,887
-231,180
| -6% | -$71.6M |
2015 Q1
43 quarters
|
|
36
ConocoPhillips
COP
$170B
| $1.08B | 0.82% |
11,577,465
+1,226,455
| +12% | +$111M |
2024 Q1
7 quarters
|
|
37
Elanco Animal Health
ELAN
$11.8B
| $1.05B | 0.79% |
46,214,088
-3,744,068
| -7% | -$81.5M |
2018 Q3
29 quarters
|
|
38
Novartis
NVS
$286B
| $1.04B | 0.79% |
7,579,274
-1,762,580
| -19% | -$231M |
2013 Q2
50 quarters
|
|
39
NetApp
NTAP
$42.2B
| $971M | 0.74% |
9,068,055
-562,000
| -6% | -$64.2M |
2013 Q2
50 quarters
|
|
40
Northern Trust
NTRS
$30.3B
| $903M | 0.68% |
6,607,717
-933,650
| -12% | -$123M |
2016 Q1
39 quarters
|
|
41
BioMarin Pharmaceuticals
BMRN
$10.8B
| $865M | 0.65% |
14,549,314
-679,973
| -4% | -$37M |
2013 Q2
50 quarters
|
|
42
Analog Devices
ADI
$196B
| $852M | 0.64% |
3,141,640
-138,480
| -4% | -$34.8M |
2013 Q2
50 quarters
|
|
43
Aecom
ACM
$7.6B
| $826M | 0.63% |
8,667,283
-211,080
| -2% | -$24.8M |
2013 Q2
50 quarters
|
|
|
44
Wells Fargo
WFC
$248B
| $779M | 0.59% |
8,360,272
-6,566,583
| -44% | -$570M |
2013 Q2
50 quarters
|
|
45
Jabil
JBL
$30.1B
| $762M | 0.58% |
3,343,670
+12,600
| +0.4% | +$2.69M |
2013 Q2
50 quarters
|
|
46
American Airlines Group
AAL
$8.13B
| $751M | 0.57% |
49,002,554
-639,385
| -1% | -$8.63M |
2013 Q4
48 quarters
|
|
47
Walt Disney
DIS
$191B
| $710M | 0.54% |
6,236,627
-10,879
| -0.2% | -$1.2M |
2013 Q2
50 quarters
|
|
48
Intuit
INTU
$88.2B
| $700M | 0.53% |
1,056,337
-65,115
| -6% | -$43M |
2013 Q2
50 quarters
|
|
49
Royal Caribbean
RCL
$74.9B
| $672M | 0.51% |
2,410,521
-346,400
| -13% | -$97.9M |
2013 Q2
50 quarters
|
|
50
Nextpower Inc. Common Stock
NXT
$12.7B
| $606M | 0.46% |
6,951,597
-508,854
| -7% | -$46.1M |
2023 Q1
11 quarters
|
|
Similar funds
Primecap Management's Q4 2025 Portfolio in Review
As of Q4 2025, Primecap Management held 337 positions worth $132B, up 1.2% from $131B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $10.4B in Q4 2025, closing 18 positions and reducing 221 holdings. Its most notable exit was Electronic Arts, an estimated $68.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Qnity Electronics Inc worth $79.4M.
- Primecap Management's largest Q4 2025 buy was Qnity Electronics Inc: 972,974 shares worth $79.4M.
- Primecap Management added most to Amazon in Q4 2025, an estimated $353M increase.
- Primecap Management's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $1.46B.
- Primecap Management fully exited Electronic Arts in Q4 2025, selling an estimated $68.4M.
- Primecap Management's ten largest holdings make up 33% of its $132B portfolio in Q4 2025.
- Primecap Management opened 10 new positions and closed 18 in Q4 2025.
- Primecap Management's portfolio value rose 1.2% quarter-over-quarter to $132B.
Based on Primecap Management's 13F filing for Q4 2025, filed 11 Feb 2026.